Sign In
Buy LLY
$1,131.42
+6.04 (+0.537%)
At Close: Jun 05, 2026
Just Two Months After IPO, BioAge Labs Stops Eli Lilly-Collaborated Obesity Trial On Safety Concerns
07:41am, Monday, 09'th Dec 2024
On Friday, BioAge Labs Inc. BIOA announced that it will discontinue the ongoing STRIDES Phase 2 study of its investigational drug candidate, azelaprag.
Mounjaro searches soar after NHS go-ahead
07:35am, Monday, 09'th Dec 2024
Online searches for Eli Lilly and Co's (NYSE:LLY) weight loss and diabetes drug Mounjaro have soared more than four-fold since the NHS received approval for weight loss programmes last week. UK drug
The Zacks Analyst Blog Eli Lilly, Novo Nordisk's Amgen and Viking Therapeutics
06:46am, Monday, 09'th Dec 2024
Eli Lilly, Novo Nordisk's Amgen and Viking Therapeutics are included in this Analyst Blog.
Eli Lilly Stock Just Got Even Sweeter. Here's Why It's Worth Buying Now
04:59am, Monday, 09'th Dec 2024
According to a sneak peek of the data from one of Eli Lilly's (LLY 0.13%) late-stage clinical trials, the cardiometabolic medicine juggernaut now looks even stronger in comparison to its similarly pow
3 No-Brainer Growth Stocks to Buy in December
06:46am, Saturday, 07'th Dec 2024
Growth. It's what most investors want more than anything else from their stocks. Some stocks can deliver more of it than others.
Could Eli Lilly Beat Rivals in the Billion-Dollar Weight Loss Drug Market in 2025? Evidence Is Piling Up, and Here's What It Says.
03:15am, Saturday, 07'th Dec 2024
Eli Lilly (LLY 0.13%) has produced a wide variety of treatments for various illnesses throughout its 145-year history. But this big pharma company truly took center stage over the past year or so, wit
Eli Lilly to Invest $3B in Wisconsin Plant to Meet Obesity Drug Demand
11:35am, Friday, 06'th Dec 2024
Per Lilly, this is its single-largest manufacturing investment in the country outside its home state. It plans to start construction on the expansion next year.
How to Play LLY Stock as Zepbound Beats NVO's Wegovy in Obesity Study
09:06am, Friday, 06'th Dec 2024
The latest Zepbound data bodes well for Lilly and could help establish the drug as the new standard for obesity medications.
Eli Lilly makes $3bn US investment as demand for weight loss drugs rises
06:54am, Friday, 06'th Dec 2024
Eli Lilly and Co (NYSE:LLY) has announced a $3 billion expansion of its manufacturing plant in Kenosha County, Wisconsin, driven by increasing demand for GLP-1 receptor agonists such as the company'
Billionaire Izzy Englander Is Buying This Obesity Drug Stock That Could Soar Nearly 20%, According to Wall Street
05:47am, Friday, 06'th Dec 2024
Most of Israel "Izzy" Englander's favorite stocks these days are technology leaders. At least that's the conclusion you'd draw based on the top holdings of the billionaire's Millennium Management hedg
Eli Lilly Chief Scientific Officer explains Zepbound's weight loss advantage
06:02pm, Thursday, 05'th Dec 2024
Dan Skovronsky, Eli Lilly Chief Scientific Officer, joins 'Fast Money' to talk Zepbound's recent trial results and what it means for Eli Lilly's future growth.
Lilly invests $3 billion to expand Wisconsin plant as obesity drug demand soars
03:40pm, Thursday, 05'th Dec 2024
Eli Lilly said on Thursday it will invest $3 billion to expand the manufacturing plant it bought in Pleasant Prairie, Wisconsin earlier this year, as it scrambles to meet soaring demand for its weight
Lilly announces $3 billion expansion of its recently acquired manufacturing facility in Wisconsin
03:30pm, Thursday, 05'th Dec 2024
The investment will benefit millions of patients worldwide, boosting the production of the company's medicines, including those for diabetes and obesity INDIANAPOLIS , Dec. 5, 2024 /PRNewswire/ -- E
LLY's Zepbound Outshines NVO's Wegovy in Head-to-Head Obesity Study
07:36am, Thursday, 05'th Dec 2024
LLY's obesity drug, Zepbound, shows an average weight loss of 20.2%, superior to 13.7% for NVO's Wegovy in a head-to-head study.
This Healthcare Stock Is a Favorite of Billionaires. But Is It a Buy?
05:32am, Thursday, 05'th Dec 2024
Just because a bunch of billionaires all own the same stock doesn't necessarily mean it's a great pick for you. On the other hand, most billionaires have become and remained billionaires for a reason.
